Nie, Fangfang
Si, Haibo
Qin, Haojie
Wang, Yuanhe
Wang, Yongpeng
Funding for this research was provided by:
Beijing Science And Technology Innovation Medical Development Foundation (KC2021-JX-0186-139)
Chinese Anti-Cancer Society-Hengrui PARP-Inhibitor Oncology Research Fund
Article History
Received: 4 March 2025
Accepted: 14 July 2025
First Online: 25 July 2025
Change Date: 18 August 2025
Change Type: Update
Change Details: The original online version of this article was revised: Yuanhe Wang was not denoted as corresponding author. Yongpeng Wang and Yuanhe Wang were corresponding authors of the article and has been updated.
Change Date: 2 September 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12905-025-03978-8
Declarations
:
: In this case, the patient has been discharged from the hospital, the data materials used are previous, de-identified, do not reveal the patient’s privacy, do not have any impact on the patient’s diagnosis and treatment, and all have signed a pan-informed consent form, thus exempting the informed consent form.
: Written consent for the publication of images used in the manuscript was obtained from the patient.
: The authors declare no competing interests.